Next, a flow cytometry-based PBMC cytotoxicity assay was utilized to delineate whether either stimulation of NOD1 alone or a combined stimulation of NOD1 and TLR4 can strengthen the cytolytic activity of PBMCs and NK cells against K562 cancer cells. The gene discussed is TLR4; the disease is cancer.